crosses of a worldwide collection of barley cultivars and landraces with a btr1 or btr2 tester (Pourkheirandish et al., 2015) . In both cases, the 1bp and 11bp deletions of the btr1 and btr2 alleles, respectively, were demonstrated to be monophyletic. In their survey for shared haplotypes, the immediate wild ancestors of btr1 were confined to varieties of Jordan, Israel, and Turkmenistan, Uzbekistan, and Afghanistan, suggesting the Southern Levant and Central Asia as domestication centers. The analysis reveals a second independent domestication center for btr2-type cultivars in the Northern Levant comprising North Syria and the southeast of Turkey. From these two confined areas, barley cultivation spread and rendered the grain that is the world's fourth most important crop today, globally grown as mainly animal feed and brewing malt ( Figure 1A ).
The cloning and physiological characterization of the barley Btr genes provide novel insights into the evolution and domestication of different clade-and species-specific mechanisms of seed dispersal systems in grasses. Different genes and molecular mechanisms for seed shattering in rice and barley, as well as the absence of rice seed shattering QTLs in regions syntenic to the barley Btr genes, are apparent. This suggests a novel-or at least modified-pathway in the Pooideae. However, additional functional analysis of these loci in rice and other cereals is required to test this hypothesis. This will help to understand the fascinating evolution and parallel domestication of the seed dispersal system and will be instructive about the molecular basis that laid the foundation for the cultural development of modern societies. Li, C., Zhou, A., and Sang, T. (2006) . Science 311, 1936 Science 311, -1939 Lin, Z., Li, X., Shannon, L.M., Yeh, C.T., Wang, M.L., Bai, G., Peng, Z., Li, J., Trick, H.N., Clemente, T.E., et al. (2012) . Nat. Genet. 44, 720-724.
Pourkheirandish, M., Hensel, G., Kilian, B., Senthil, N., Chen, G., Sameri, M., Azhaguvel, P., Sakuma, S., Dhanagond, S., Sharma, R., et al. (2015) Although the mitochondrial electron transport chain (ETC) is best known for its role in ATP synthesis, two studies, Sullivan et al. and Birsoy et al., conclude that its only essential function in proliferating cells is making aspartate (D).
Within the inner mitochondrial membrane, 73 individual subunits translated from two distinct genomes are assembled into the four multimeric protein complexes that comprise the electron transport chain (ETC). This machine of unrivaled complexity and elegance plays a critical role in enabling the mitochondria to synthesize 34 molecules of ATP from the oxidization of one molecule of glucose. Therefore, it may be surprising that two papers published in this issue of Cell (Sullivan et al., 2015; Birsoy et al., 2015) provide compelling evidence that in proliferating cells the only essential function of these massive complexes is the biosynthesis of a single, seemingly insignificant, amino acid-aspartate, known to most scientists only as Asp or D.
The story starts with an observation made some 25 years ago by King and Attardi (1989) , who demonstrated that cells lacking mtDNA failed to proliferate as a result of ETC dysfunction, but that this could be rescued by adding supraphysiological concentrations of pyruvate to the media. While many of us have encountered this fact when culturing mammalian cells, the etiology of this phenomenon is not at all obvious. Why would pyruvate rescue the growth of cells lacking functional mtDNA, which are highly glycolytic and generate large amounts of pyruvate inherently (which is typically converted to lactate and excreted)? Sullivan et al. and Birsoy et al. clearly show that ETC dysfunction impairs the redox balance of the cell and that the operative role of pyruvate is to restore redox homeostasis by serving as an electron acceptor.
The (Birsoy et al., 2015) . Aspartate biosynthesis normally occurs in the mitochondria and requires mitochondrial malate dehydrogenase (MDH2) and its obligate NAD + co-substrate ( Figure 1A) . As a result, uncompensated ETC inhibition and NAD + depletion causes failure of the canonical pathway of aspartate synthesis. In perhaps the most surprising result of the two papers, however, addition of only exogenous aspartate is sufficient to restore proliferative capacity to ETC-deficient cells without affecting the redox state. Of all the potential problems caused by loss of ETC function, aspartate auxotrophy is the one that is rate limiting for proliferation.
In parallel, Birsoy et al. take the forward genetic approach of asking cells which metabolic pathways are important for proliferation in the presence of ETC inhibition. The cells speak loud and clear, and the message again is about aspartate. The top hit that emerges from the screen is GOT1, a cytosolic aspartate aminotransferase involved in the malate-aspartate shuttle (Figure 1 ). The authors go on to confirm that the aspartate synthesis and proliferation of cells with GOT1 deletion are much more sensitive to all forms of ETC impairment than their wild-type counterparts. Flux labeling experiments reveals that ETC competent cells synthesize aspartate through a mitochondrial oxidative pathway from TCA cyclederived oxaloacetate ( Figure 1B) . ETCdeficient cells, without sufficient NAD + , switch to a reductive biosynthetic pathway in which citrate, derived from reductive carboxylation of glutamine, is converted to oxaloacetate by ATP-citrate lyase, which can be used by GOT1 to generate aspartate in the cytosol ( Figure 1C ). This pathway, however, is not capable of synthesizing sufficient aspartate to support normal cell proliferation without a continuous supply of oxidized NAD + . This brings the story back to pyruvate and AKB as exogenous electron acceptors, which regenerate the pool of cytosolic NAD + to enable a third aspartate biosynthetic pathway requiring both GOT1 and MDH1, the NAD + -requiring cytosolic malate dehydrogenase ( Figure 1D ). These two studies provide profound and surprising insights into the metabolic consequences of ETC dysfunction and raise questions about how this plays out in a living mammal. These experiments focus on proliferating cells in culture. Would ETC dysfunction in highly proliferative cells in vivo cause a similar decrease in the NAD + /NADH ratio and cause a similar dependency on exogenous aspartate or pyruvate, which are maintained at relatively low concentrations in the blood (Kelsay et al., 1972; Wuu et al., 1988) ? Second, does ETC dysfunction have similar metabolic consequences in post-mitotic differentiated cells? Regardless of proliferative activity, depletion of cellular electron acceptors will undoubtedly impair aspartate biosynthesis and redox balance. In fact, Birsoy et al. show that mitochondrial dysfunction leads to local aspartate depletion in mice with heart-specific deletion of mitochondrial transcription factor A (Tfam). These studies suggest that redox imbalance and maybe even aspartate depletion might be components of the pathophysiology of human diseases of impaired ETC function. If so, an enhanced exogenous supply of pyruvate, AKB, or aspartate may have therapeutic benefit, for which there is already some evidence (Fujii et al., 2014) . Some tumors are also characterized by homozygous loss-of-function mutations affecting the TCA cycle enzymes, succinate dehydrogenase (SDH) and fumarate hydratase (FH), which result in similarly impaired mitochondrial ETC activity (Raimundo et al., 2011) . The data from the two studies raise the possibility that such tumor cells may be addicted to exogenous pyruvate and/or aspartate for proliferation. This is supported by the recent finding that SDH-deficient cells consume extracellular pyruvate, which promotes aspartate biosynthesis (Eyal Gottlieb, personal communication) . If so, it might be possible to exploit this liability therapeutically in the treatment of SDH-or FH-deficient tumors.
These studies also raise important but difficult questions regarding the intracellular compartmentalization of metabolite pools, particularly of NAD + /NADH (Nikiforov et al., 2015) . Despite having drastic effects of cell proliferation, ETC inhibition causes only a very mild perturbation (20%) in the NAD + /NADH ratio when measured in cell lysates. The effect sizes don't seem to match and one possible explanation is the compartmentalization of distinct pools of NAD and NADH that serve different metabolic functions. Upon ETC dysfunction, there is likely a massive depletion of NAD + in the mitochondrial matrix, which is not detected due to the overwhelmingly larger pool in the cytosol, which is either normal or mildly affected. There could also be specific cytosolic NAD + /NADH pools that are particularly sensitive to ETC dysfunction. Such hypotheses await the advent of new tools that can measure redox balance or metabolic flux with subcellular spatial resolution.
These studies provide a new perspective on the function of the ETC. At least in proliferating cells, the critical function of this system is not the generation of ATP, but rather to simply provide a route to O 2 as a terminal electron acceptor. They also add to the growing drumbeat proclaiming the central importance of proliferating cells adjusting their metabolism to support macromolecular biosynthesis even at the expense of ATP synthesis. And, who would have believed that the one essential biosynthetic requirement for the ETC is aspartate?
